Spero Therapeutics
SPRO
#8943
Rank
โ‚ฌ0.13 B
Marketcap
2,32ย โ‚ฌ
Share price
2.61%
Change (1 day)
266.43%
Change (1 year)

EPS for Spero Therapeutics (SPRO)

EPS in 2025 (TTM): -0,73ย โ‚ฌ

According to Spero Therapeutics's latest financial reports the company's current EPS (TTM) is -0,67ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -1,07ย โ‚ฌ.

EPS history for Spero Therapeutics from 2017 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,73ย โ‚ฌ-31.74%
2024-1,07ย โ‚ฌ
2022-1,40ย โ‚ฌ
2020-3,05ย โ‚ฌ9.39%
2019-2,79ย โ‚ฌ25.48%
2018-2,22ย โ‚ฌ-51.35%
2017-4,57ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
IBM
IBM
9,59ย โ‚ฌ-1,536.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Thomson Reuters
TRI
2,81ย โ‚ฌ-521.52%๐Ÿ‡จ๐Ÿ‡ฆ Canada
Franklin Covey
FC
-0,09294ย โ‚ฌ-86.08%๐Ÿ‡บ๐Ÿ‡ธ USA